Switzerland Diabetes Market will reach US$ 1.99 Billion at a CAGR of 4.71% by 2028, according to the publisher. Almost half a million people in Switzerland have diabetes, which is constantly rising. Diabetes is an essential public health paging, one of four priority non-infectious diseases targeted for action by world leaders. The prevalence of Swiss Diabetes has been steadily increasing over the past few decades. Due to population boost, urbanization, aging, and the rising prevalence of obesity, the number of individuals with Diabetes is growing. Improving glycemic control is associated with reducing late complications of Diabetes, such as cardiovascular and micro vascular diseases. Therefore, treatment guidelines were established internationally by prominent and renowned associations and adopted by many countries.Switzerland Diabetes Market will reach US$ 1.99 Billion in 2028
Type 2 Diabetes is Increasing Year on Year
In Switzerland, Diabetes affects approximately 5% of the population; type 2 diabetes, the most common type, affects about 500,000 people, while type 1 diabetes affects about 40,000 people, according to the Swiss Medical Net. Diabetes can lead to complications in many body parts and increase the risk of dying prematurely. Possible complications include kidney failure, leg amputation, heart attack, stroke, nerve damage, and vision loss.In addition, patients with T2D must have a BMI of = 28 kg/m2 for health insurance to reimburse semaglutide treatment. This may have had implications for the patients enrolled in SURE Switzerland. According to our research study Diabetes Market in Switzerland was valued at US$ 1.51 Billion in 2022.
Increasing Number of Diabetes in Switzerland will create more demand for Insulin Pen Market
Based on devices, Switzerland Diabetes Market is classified into four types: Glucose Monitoring (CGM), Self-Monitoring Blood Glucose (SMBG), and Insulin Pump and Insulin Pens. Insulin pens will hold the maximum share during the upcoming years due to the rising prevalence of Diabetes in various age groups; increasing R&D activities also boost the insulin pen market. Currently, over 95% of the insulin used in Switzerland is sold in a concentration of 40 units per ml. However, only recently, a small but increasing amount of more concentrated insulin has been introduced through 'pen' injectors designed for U-100 (= 100 units per ml) insulin.With the greater ease of use of insulin pens, people in Switzerland with visual impairment or reduced dexterity may significantly benefit from using an insulin pen rather than a vial and syringe. However, once in use, most insulin analog vials, cartridges, and prefilled pens must be discarded after 28 days. Moreover, SMBG, Insulin Pumps, and CMG will also grow in Switzerland during the upcoming year. The Insulin Pump is especially suitable for patients with type-1 Diabetes who require a continuous supply of insulin and need to balance every meal with additional insulin.
Switzerland Health Policy
The Swiss healthcare system's duties and responsibilities are divided among cantonal, federal and municipal governments. Each of the 26 cantons was responsible for licensing providers, coordinating hospital services, promoting health through disease prevention, and subsidizing institutions and individual premiums. The federal government regulates system financing, ensures the safety and quality of pharmaceuticals and medical devices, oversees public health initiatives, and promotes research and training. The municipalities organize and provide long-term care (nursing home care and home care services) and other social support services for vulnerable groups.Key Company
The Netherlands Diabetes Market comprises major manufacturers, B. Braun Melsungen AG, Sanofi, Eli Lilly and Company, Becton Dickenson (BD), Novo Nordisk A/S, Ypsomed AG, Biocon, Medtronic, Insulet Corporation, Abbott Laboratories, Terumo Corporation, and Dexcom Inc.In May 2021, Medtronic secured European approvals for its Guardian 4 sensor. The Guardian 4 sensor can be either utilized as a standalone continuous glucose monitor or combined into Medtronic's insulin pumps and pens to add real-time glucose monitoring alongside insulin tracking.
This report titled “Switzerland Diabetes Market & Forecast, By Continuous Glucose Monitoring Analysis (Glucose Sensor Market &Forecast, CGM Transmitter Market& Forecast, CGM User, and CGM Reimbursement), Self-Monitoring Blood GlucoseAnalysis(Test Strips Market& Forecast, Lancet Market & Forecast, Meter Market and Forecast, Blood Glucose (SMBG) Users and Blood Glucose Devices Reimbursement), Insulin Pen Analysis (Disposable Insulin Pen, Reusable Insulin Pen, Smart Insulin Pen, insulin Pen Needle Market, insulin Pen Users, and reimbursement Policies), Insulin Pump Analysis (Insulin Pump Market, Insulin Pump Users, Insulin Pump Products and Reimbursement), Companies (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Cororation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of Switzerland Diabetes Market.
Switzerland Segments Market based on Devices
Segments Market based on Devices
1. Continuous Glucose Monitoring (CGM)2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump
Switzerland Diabetes Sub-Segment Analysis
1. Continuous Glucose Monitoring (CGM)1. Glucose Sensor Market & Forecast
2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement
2. SMBG
1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
3. Insulin Pen Market
1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies
4. Insulin Pump Market
1. Insulin Pump Market
2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies
All the 13 Companies Studied in the Report have been Studied from 3 Points
- Company Overview
- Recent Developments
- Financial Insight
Company Analysis
1. B. Braun Melsungen AG2. Eli Lilly and Company
3. Terumo Corporation
4. Becton, Dickinson (BD)
5. Novo Nardisk
6. Ypsomed AG
7. Medtronic
8. Insulet Cororation
9. Abbott Laboratories
10. DarioHealth Crop
11. Dexcom, Inc
12. Roche Diagnostic
13. Tandem Diabetes Care
Table of Contents
1. Introduction2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Switzerland Diabetes Market
6. Switzerland Diabetes Population
6.1 Type 1 Diabetes
6.2 Type 2 Diabetes
7. Switzerland Diabetes Market Share Analysis
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) - Market & Users
8.1 Switzerland - CGM Market by Components
8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market
8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in Switzerland
9. Blood Glucose Device (SMBG) - Switzerland Market & Users
9.1 Market
9.1.1 Type 1 Diabetes Market
9.1.2 Type 2 Diabetes Market
9.2 Test Strips Market
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.3 Lancet Market
9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes
9.4 Meter Market and Forecast
9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes
9.5 Blood Glucose (SMBG) Users
9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes
9.6 Reimbursement Policies of Blood Glucose Devices in Switzerland
10. Insulin Pen - Switzerland Market & User Analysis
10.1 Insulin Pen Market
10.1.1 Disposable Insulin Pen Market
10.1.2 Reusable Insulin Pen Market
10.1.3 Smart Insulin Pen Market
10.2 Insulin Pen Needle Market
10.3 Insulin Pen User
10.3.1 Disposable Insulin Pen User
10.3.2 Reusable Insulin Pen User
10.3.3 Smart Insulin Pen User
10.4 Reimbursement Policies of Insulin Pen in Switzerland
11. Insulin Pump - Switzerland Market & Users
11.1 Insulin Pump Market
11.1.1 Type 1 Diabetes Market
11.1.2 Type 2 Diabetes Market
11.2 Insulin Pump User
11.2.1 Type 1 Insulin Pump User
11.2.2 Type 2 Insulin Pump User
11.3 Differentiation Points of Insulin Pump Products in Switzerland
12. Insulin Pen - Company Analysis
12.1 B. Braun Melsungen AG
12.1.1 Overview
12.1.2 Recent Developments
12.1.3 Revenue
12.2 Eli Lilly
12.2.1 Overview
12.2.2 Recent Developments
12.2.3 Revenue
12.3 Terumo Corporation
12.3.1 Overview
12.3.2 Recent Developments
12.3.3 Revenue
12.4 BD
12.4.1 Overview
12.4.2 Recent Developments
12.4.3 Revenue
12.5 Novo Nordisk A/S
12.5.1 Overview
12.5.2 Recent Developments
12.5.3 Revenue
12.6 Ypsomed AG
12.6.1 Overview
12.6.2 Recent Developments
12.6.3 Revenue
13. Insulin Pump - Company Analysis
13.1 Medtronic
13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Revenue
13.2 Insulet Corporation
13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Revenue
14. SMBG - Company Analysis
14.1 DarioHealth Corp
14.1.1 Overview
14.1.2 Recent Developments
14.1.3 Revenue
14.2 Abbott Laboratories
14.2.1 Overview
14.2.2 Recent Developments
14.2.3 Revenue
15. CGM - Company Analysis
15.1 Dexcom Inc
15.1.1 Overview
15.1.2 Recent Developments
15.1.3 Revenue
15.2 Roche
15.2.1 Overview
15.2.2 Recent Developments
15.2.3 Revenue
15.3 Tandem Diabetes Care
15.3.1 Overview
15.3.2 Recent Developments
15.3.3 Revenue
List of Figures:
Figure 01: Switzerland - Diabetes Market (Billion US$), 2017 - 2022
Figure 02: Switzerland - Forecast for Diabetes Market (Billion US$), 2023 - 2028
Figure 03: Switzerland - Type 1 Diabetes Population (Thousand), 2017 - 2022
Figure 04: Switzerland - Forecast for Type 1 Diabetes Population (Thousand), 2023 - 2028
Figure 05: Switzerland - Type 2 Diabetes Population (Thousand), 2017 - 2022
Figure 06: Switzerland - Forecast for Type 2 Diabetes Population (Thousand), 2023 - 2028
Figure 07: Switzerland - Glucose Sensor Market (Million US$), 2017 - 2023
Figure 08: Switzerland - Forecast for Glucose Sensor Market (Million US$), 2023 - 2028
Figure 09: Switzerland - CGM Transmitter Market (Million US$), 2017 - 2023
Figure 10: Switzerland - Forecast for CGM Transmitter Market (Million US$), 2023 - 2028
Figure 11: Switzerland - CGM User (Number), 2017 - 2023
Figure 12: Switzerland - Forecast for CGM User (Number), 2023 - 2028
Figure 13: Switzerland - Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 14: Switzerland - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 15: Switzerland - Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 16: Switzerland - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 17: Switzerland - Test Strips Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 18: Switzerland - Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 19: Switzerland - Test Strips Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 20: Switzerland - Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 21: Switzerland - Lancet Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 22: Switzerland - Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 23: Switzerland - Lancet Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 24: Switzerland - Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 25: Switzerland - Meter Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 26: Switzerland - Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 27: Switzerland - Meter Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 28: Switzerland - Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 29: Switzerland - Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 - 2022
Figure 30: Switzerland - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 - 2028
Figure 31: Switzerland - Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 - 2022
Figure 32: Switzerland - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 - 2028
Figure 33: Switzerland - Disposable Insulin Pen Market (Million US$), 2017 - 2023
Figure 34: Switzerland - Forecast for Disposable Insulin Pen Market (Million US$), 2023 - 2028
Figure 35: Switzerland - Reusable Insulin Pen Market (Million US$), 2017 - 2023
Figure 36: Switzerland - Forecast for Reusable Insulin Pen Market (Million US$), 2023 - 2028
Figure 37: Switzerland - Smart Insulin Pen Market (Million US$), 2017 - 2023
Figure 38: Switzerland - Forecast for Smart Insulin Pen Market (Million US$), 2023 - 2028
Figure 45: Switzerland - Insulin Pen Needle Market (Million US$), 2017 - 2023
Figure 46: Switzerland - Forecast for Pen Needle Market (Million US$), 2023 - 2028
Figure 39: Switzerland - Disposable Insulin Pen User (Thousand), 2017 - 2022
Figure 40: Switzerland - Forecast for Disposable Insulin Pen User (Thousand), 2023 - 2028
Figure 41: Switzerland - Reusable Insulin Pen User (Thousand), 2017 - 2022
Figure 42: Switzerland - Forecast for Reusable Insulin Pen User (Thousand), 2023 - 2028
Figure 43: Switzerland - Smart Insulin Pen User (Thousand), 2017 - 2022
Figure 44: Switzerland - Forecast for Smart Insulin Pen User (Thousand), 2023 - 2028
Figure 47: Switzerland - Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 48: Switzerland - Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 49: Switzerland - Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 50: Switzerland - Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 51: Switzerland - Insulin Pump Type 1 Users (Thousand), 2017 - 2022
Figure 52: Switzerland - Forecast for Insulin Pump Type 1 Users (Thousand), 2023 - 2028
Figure 53: Switzerland - Insulin Pump Type 2 Users (Thousand), 2017 - 2022
Figure 54: Switzerland - Forecast for Insulin Pump Type 2 Users (Thousand), 2023 - 2028
Figure 55: B. Braun Melsungen AG - Global Revenue (Billion US$), 2017 - 2022
Figure 56: B. Braun Melsungen AG - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 57: Eli Lilly - Global Revenue (Million US$), 2017 - 2022
Figure 58: Eli Lilly - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 59: Terumo Corporation - Global Revenue (Billion US$), 2017 - 2022
Figure 60: Terumo Corporation - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 61: BD - Global Revenue (Billion US$), 2017 - 2022
Figure 62: BD - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 63: Novo Nordisk A/S - Global Revenue (Million US$), 2017 - 2022
Figure 64: Novo Nordisk A/S - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 65: Ypsomed AG - Global Revenue (Million US$), 2017 - 2022
Figure 66: Ypsomed AG - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 67: Medtronic - Global Revenue (Billion US$), 2017 - 2022
Figure 68: Medtronic - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 69: Insulet Corporation - Global Revenue (Million US$), 2017 - 2022
Figure 70: Insulet Corporation - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 71: DarioHealth Corp - Global Revenue (Million US$), 2017 - 2022
Figure 72: DarioHealth Corp - Forecast for Global Revenue (Million US$), 2023 - 2028
Figure 73: Abbott Laboratories - Global Revenue (Billion US$), 2017 - 2022
Figure 74: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 75: Dexcom Inc - Global Revenue (Billion US$), 2017 - 2022
Figure 76: Dexcom Inc - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 77: Roche - Global Revenue (Billion US$), 2017 - 2022
Figure 78: Roche - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 79: Tandem Diabetes Care - Global Revenue (Million US$), 2017 - 2022
Figure 80: Tandem Diabetes Care - Forecast for Global Revenue (Million US$), 2023 - 2028
List of Tables:
Table 01: Switzerland - Diabetes Market Share by Type (Percent), 2017 - 2022
Table 02: Switzerland - Forecast for Diabetes Market Share by Type (Percent), 2023 - 2028
Companies Mentioned
- B. Braun Melsungen AG
- Eli Lilly and Company
- Terumo Corporation
- Becton, Dickinson (BD)
- Novo Nardisk
- Ypsomed AG
- Medtronic
- Insulet Cororation
- Abbott Laboratories
- DarioHealth Crop
- Dexcom, Inc
- Roche Diagnostic
- Tandem Diabetes Care
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 190 |
| Published | March 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 1.51 Billion |
| Forecasted Market Value ( USD | $ 1.99 Billion |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Switzerland |
| No. of Companies Mentioned | 13 |
